Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome

Thrombocytopenia is a frequent symptom and clinical challenge in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Eltrombopag is a small molecule thrombopoietin receptor agonist that might be a new option to treat thrombocytopenia in these diseases, provided that it doe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Will, Britta, Kawahara, Masahiro, Luciano, Julia P., Bruns, Ingmar, Parekh, Samir, Erickson-Miller, Connie L., Aivado, Manuel A., Verma, Amit, Steidl, Ulrich
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2009
Materias:
Myeloid Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2773490/
https://ncbi.nlm.nih.gov/pubmed/19710504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-04-219493
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares